ASH1L antisense RNA 1 (ASH1L-AS1)

ASH1L-AS1 (ASH1L antisense RNA 1) is a long non-coding RNA transcribed antisense to the ASH1L gene. Its canonical abbreviation is ASH1L-AS1. There is substantial ambiguity in the information provided about aliases like "APPLE" and "a peptide located in ER"; these do not conform to standard gene or lncRNA nomenclature and are likely either misattributions or database errors. ASH1L-AS1 itself is not considered a therapeutic target, and there is no evidence it is a receptor, enzyme, transporter, transcription factor, or possesses any known function in drug action or clinical biomarker utility. It is primarily a non-protein coding RNA with uncharacterized biological functions and unclear disease association. There are no approved drugs or mechanisms of action linked to ASH1L-AS1. Standard molecular databases do not support APPLE or "a peptide located in ER" as proper aliases for this lncRNA; these should be flagged as potentially erroneous or misleading. Note: ASH1L, by contrast, is a well-characterized histone methyltransferase (KMT2H) with important roles in transcriptional regulation, development, neurological disease, and cancer[1][3][4]. If the intended query was about ASH1L (protein), that is a recognized therapeutic target, but ASH1L-AS1 (the antisense RNA) does not currently meet criteria for therapeutic targeting and does not have a well-established biological or disease function. The provided aliases are inconsistent and likely incorrect for clinical or biological data mapping.

Other names

APPLEa peptide located in ERASH1L antisense RNA 1 (non-protein coding)ASH1L-AS1